NCT03042143View on ClinicalTrials.gov

Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration (REALIST)

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

January 7, 2019

Primary Completion Date

April 30, 2026

Study Completion Date

October 31, 2026

Conditions
Acute Respiratory Distress Syndrome
Interventions
BIOLOGICAL

Human umbilical cord derived CD362 enriched MSCs

Infusion of Human umbilical cord derived CD362 enriched MSCs

BIOLOGICAL

Placebo (Plasma-Lyte 148)

Infusion of placebo

Trial Locations (1)

BT12 6BA

Belfast Health and Social Care Trust, Royal Hospitals, Belfast

Sponsors
All Listed Sponsors
collaborator

Queen's University, Belfast

OTHER

collaborator

Northern Ireland Clinical Trials Unit

OTHER

collaborator

NHS Blood and Transplant

OTHER_GOV

lead

Belfast Health and Social Care Trust

OTHER

NCT03042143 - Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration (REALIST) | Biotech Hunter | Biotech Hunter